New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has successfully finished patient enrolment for TRANSFORM II, one of the most ambitious and extensive randomised controlled trials (RCTs) ever carried out in the field of cardiovascular care, at a pivotal point for the future of interventional cardiology.
Wednesday, July 30
Trending
- Stronger Together: India and UAE Seal Strategic Defence Boost at 13th JDCC Meet
- Mukkti Foundation and Smita Thackeray Launch Free Kala & Natya Workshop for Underprivileged Children
- Eco Recycling Reports Rs 8 Cr PAT, up 268 Percent in Consolidated Q1 FY26
- Avani Institute of Design Launches Innovative Five-Year Integrated B.Des + M.Des Dual Degree Program
- Aayush Wellness Announces 2nd Interim Dividend
- How Vivanta Stays Is Quietly Shaking Up India’s Luxury Villa Market With Heart and Hustle
- Dragon Tattoos Gallery, A Leading Tattoo Studio in Ahmedabad
- DPIIT Partners with TICE to Boost Startup Visibility and Media Outreach Across India